MX, L., ZF, Z., & ZW, C. (2026). Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease. Clinical laboratory, 72(6), . https://doi.org/10.7754/Clin.Lab.2025.250536
Chicago Style (17th ed.) CitationMX, Li, Zeng ZF, and Cao ZW. "Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease." Clinical Laboratory 72, no. 6 (2026). https://doi.org/10.7754/Clin.Lab.2025.250536.
MLA (9th ed.) CitationMX, Li, et al. "Mendelian Randomization and Transcriptomic Analysis Identify HE4 as a Potential Biomarker for Chronic Obstructive Pulmonary Disease." Clinical Laboratory, vol. 72, no. 6, 2026, https://doi.org/10.7754/Clin.Lab.2025.250536.